Sathyanarayanan Sriram 4
4 · Codiak BioSciences, Inc. · Filed Jan 21, 2022
Insider Transaction Report
Form 4
Sathyanarayanan Sriram
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-19+45,000→ 45,000 totalExercise: $7.21Exp: 2032-01-18→ Common Stock (45,000 underlying) - Award
Restricted Stock Units
2022-01-19+8,500→ 8,500 total→ Common Stock (8,500 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on January 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On January 19, 2022, the reporting person was granted 8,500 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.